Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ZALEPLON vs ZANIDATAMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ZALEPLON vs ZANIDATAMAB: Safety Overview

Metric ZALEPLON ZANIDATAMAB
Total FAERS Reports 381 142
Deaths Reported 100 12
Death Rate 26.2% 8.5%
Hospitalizations 52 125
Average Patient Age 60.4 yrs 65.2 yrs
% Female Patients 66.5% 40.2%
FDA Approval Date Aug 13, 1999 N/A
Manufacturer Hikma Pharmaceuticals USA Inc. Jazz Pharmaceuticals, Inc.
Route ORAL INTRAVENOUS
Marketing Status Discontinued N/A